deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT00783471

Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC) (DOPERLO)

Docetaxel Combined With Pulsatile Erlotinib (Tarceva®) In Patients With Metastatic Non Small Cell Lung Cancer (NSCLC) (DOPERLO)

Sponsor: Hellenic Cooperative Oncology Group

Conditions Advanced Non-Small Cell Lung Cancer
Interventions Docetaxel, Erlotinib Erlotinib, Docetaxel
Updated 9 times since 2017 Last updated: Jun 15, 2010 Started: Nov 30, 2008 Primary completion: May 31, 2010 Completion: Jun 30, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The low accrual rate of the study (30% of the expected accrual rate)/Low efficacy in both treatment arms.

Other terminated trials from Hellenic Cooperative Oncology Group

More terminations from Hellenic Cooperative Oncology Group

This PHASE2 trial investigates Advanced Non-Small Cell Lung Cancer and is currently terminated or withdrawn. Hellenic Cooperative Oncology Group leads this study, which shows 9 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotTerminated~Aug 2017 – ~May 2018 · 9 months · monthly snapshotTerminated~May 2018 – ~Jun 2018 · 31 days · monthly snapshotTerminated~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotTerminated~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE2

  5. Nov 2020 — Jan 2021 [monthly]

    Terminated PHASE2

▶ Show 4 earlier versions

  1. Jun 2018 — Nov 2020 [monthly]

    Terminated PHASE2

  2. May 2018 — Jun 2018 [monthly]

    Terminated PHASE2

  3. Aug 2017 — May 2018 [monthly]

    Terminated PHASE2

  4. Jan 2017 — Aug 2017 [monthly]

    Terminated PHASE2

    First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hellenic Cooperative Oncology Group
Data source: Hellenic Cooperative Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations